Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1
Hye‐Kyung Park(Ulsan National Institute of Science and Technology), Byoung Heon Kang(Cheongju University)
Cited by 143
Related Papers
Combination treatment with doxorubicin and gamitrinib synergistically augments anticancer activity through enhanced activation of Bim
|BMC Cancer|2014|60
Targeting the Mitochondrial Chaperone TRAP1 Alleviates Vascular Pathologies in Ischemic Retinopathy
|Advanced Science|2023|18
Pseudohypoxic stabilization of HIF1α via cyclophilin D suppression promotes melanoma metastasis
|Signal Transduction and Targeted Therapy|2025|4